Page last updated: 2024-08-25

chitosan and Hyperlipemia

chitosan has been researched along with Hyperlipemia in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's3 (21.43)29.6817
2010's7 (50.00)24.3611
2020's3 (21.43)2.80

Authors

AuthorsStudies
Basak, S; Ghosh, N; Gopal Sahoo, N; Karmakar, T; Wang, Y1
Abd El Maksoud, AI; Abourehab, MAS; Ali, MA; El Hassab, MA; Eldehna, WM; Elebeedy, D; Ghanem, A; Ibrahim, MH; Kamaly, OA; Saleh, A1
Koumaravelou, K; Sarathchandiran, I; Selvasudha, N1
Chen, L; He, H; Jiang, Y; Luo, X; Wang, C; Wang, N; Wang, Q; Zhang, T1
Jiang, Q; Wang, B; Wang, X; Xia, W; Xu, Y; Yang, S; Zhang, S1
Bai, Y; Cao, H; Deng, X; Guo, J; Hu, C; Su, Z; Yang, D1
Qin, C; Wang, L; Wang, Z; Yan, Y; Zhang, F; Zhang, Z1
Cai, K; Chen, X; Ding, X; Hou, Y; Li, J; Liu, Y; Shen, X1
Ahmed, TA; Kurakula, M1
Guo, J; Hu, YM; Su, ZQ; Tao, Y; Zhang, HL1
Amigone, JL; Ausar, SF; Beltramo, DM; Bianco, ID; Castagna, LF; Diaz, G; León, AE; Lescano, C; Masih, R; Morcillo, M; Ribotta, PD; Rubin, G; Vilaro Mainero, M1
Hu, Y; Huang, X; Qiu, L; Wu, J; Xu, G1
Chobot, V; Kremenák, J; Opletal, L1
Peng, LH1

Other Studies

14 other study(ies) available for chitosan and Hyperlipemia

ArticleYear
Targeting mangiferin loaded N-succinyl chitosan-alginate grafted nanoparticles against atherosclerosis - A case study against diabetes mediated hyperlipidemia in rat.
    Food chemistry, 2022, Feb-15, Volume: 370

    Topics: Alginates; Animals; Atherosclerosis; Chitosan; Diabetes Mellitus; Hyperlipidemias; Molecular Docking Simulation; Nanoconjugates; Nanoparticles; Particle Size; Rats; Spectroscopy, Fourier Transform Infrared; Xanthones

2022
In Vivo and In Silico Investigation of the Anti-Obesity Effects of
    International journal of molecular sciences, 2022, Oct-13, Volume: 23, Issue:20

    Topics: Animals; Catalase; Chitosan; Diet, High-Fat; Hyperlipidemias; Inflammation; Male; Malondialdehyde; Obesity; Rats; Rats, Sprague-Dawley; Seeds; Superoxide Dismutase; Tea

2022
Interaction pattern and
    Drug development and industrial pharmacy, 2019, Volume: 45, Issue:11

    Topics: Administration, Oral; Animals; Chitosan; Cholesterol, Dietary; Delayed-Action Preparations; Disease Models, Animal; Drug Administration Schedule; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Hyperlipidemias; Mice; Molecular Docking Simulation; Nanoparticles; Particle Size; Proton Magnetic Resonance Spectroscopy; Simvastatin; Spectroscopy, Fourier Transform Infrared

2019
Chitooligosaccharides Modulate Glucose-Lipid Metabolism by Suppressing SMYD3 Pathways and Regulating Gut Microflora.
    Marine drugs, 2020, Jan-20, Volume: 18, Issue:1

    Topics: Animals; Chitosan; Diabetes Mellitus, Type 2; Dysbiosis; Dyslipidemias; Gastrointestinal Microbiome; Glucose; Hep G2 Cells; Histone-Lysine N-Methyltransferase; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperglycemia; Hyperlipidemias; Kidney; Lipid Metabolism; Lipogenesis; Liver; Male; Mice; Oligosaccharides

2020
Transcriptome analysis of the effects of chitosan on the hyperlipidemia and oxidative stress in high-fat diet fed mice.
    International journal of biological macromolecules, 2017, Volume: 102

    Topics: Adipose Tissue; Animals; Body Weight; Chitosan; Diet, High-Fat; Epididymis; Gene Expression Profiling; Gene Ontology; Hyperlipidemias; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; Oxidative Stress

2017
Therapeutic Effect of Chitooligosaccharide Tablets on Lipids in High-Fat Diets Induced Hyperlipidemic Rats.
    Molecules (Basel, Switzerland), 2019, Jan-31, Volume: 24, Issue:3

    Topics: Adipose Tissue; Adiposity; Animals; Biomarkers; Chitin; Chitosan; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Hyperlipidemias; Kidney; Lipid Metabolism; Lipids; Liver; Oligosaccharides; Oxidation-Reduction; Rats; Tablets

2019
Lipid-lowering activities of chitosan and its quaternary ammonium salt for the hyperlipidemia rats induced by high-fat diets.
    International journal of biological macromolecules, 2019, Jul-01, Volume: 132

    Topics: Animals; Chitosan; Diet, High-Fat; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipids; Liver; Male; Oxidative Stress; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley

2019
Recyclable heparin and chitosan conjugated magnetic nanocomposites for selective removal of low-density lipoprotein from plasma.
    Journal of materials science. Materials in medicine, 2014, Volume: 25, Issue:4

    Topics: Adsorption; Biocompatible Materials; Blood Component Removal; Chitosan; Heparin; Humans; Hyperlipidemias; Lipoproteins, LDL; Magnetic Phenomena; Magnetite Nanoparticles; Materials Testing; Nanocomposites; Particle Size; Recycling

2014
Co-Delivery of Atorvastatin Nanocrystals in PLGA based in situ Gel for Anti-Hyperlipidemic Efficacy.
    Current drug delivery, 2016, Volume: 13, Issue:2

    Topics: Anticholesteremic Agents; Atorvastatin; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Liberation; Gels; Hyperlipidemias; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solvents; Surface Properties; X-Ray Diffraction

2016
Hypolipidemic effects of chitosan nanoparticles in hyperlipidemia rats induced by high fat diet.
    International immunopharmacology, 2011, Volume: 11, Issue:4

    Topics: Animals; Blood Viscosity; Chitosan; Dietary Fats; Disease Models, Animal; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Toxicity Tests, Acute

2011
Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan.
    Journal of medicinal food, 2003,Winter, Volume: 6, Issue:4

    Topics: Blood Glucose; Body Weight; Bread; Chitin; Chitosan; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Food Additives; Glycated Hemoglobin; Humans; Hyperlipidemias; Treatment Outcome; Triglycerides

2003
Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats.
    Asia Pacific journal of clinical nutrition, 2007, Volume: 16 Suppl 1

    Topics: Animals; Anticholesteremic Agents; Bile Acids and Salts; Cellulose; Chitosan; Cholesterol; Feces; Hyperlipidemias; Lipid Metabolism; Lipids; Lipoproteins; Liver; Male; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, LDL; RNA, Messenger; Triglycerides

2007
[Phytotherapeutic aspects of diseases of the circulatory system. 4. Chitin and chitosan].
    Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 1995, Volume: 44, Issue:4

    Topics: Anticholesteremic Agents; Chitin; Chitosan; Humans; Hyperlipidemias; Thrombosis

1995
Article: In the absence of dietary surveillance, chitosan does not reduce plasma lipids...(SC Ho, et al)(SMJ Vol 42 Issue 1 January 2001.
    Singapore medical journal, 2001, Volume: 42, Issue:5

    Topics: Chitin; Chitosan; Clinical Trials as Topic; Humans; Hyperlipidemias; Lipids; Reproducibility of Results; Sample Size

2001